Elevated bladder cancer risk with pioglitazone use

Use of the antidiabetic drug pioglitazone is linked to an increased risk of developing bladder cancer, with the risk rising with increasing duration of use and dose, say Canadian researchers.
Source: MedWire News - Category: Consumer Health News Tags: Oncology Source Type: news